⚠
✓
Open Orphan Plc
Open Orphan Plc
Sector: Healthcare
Description
Open Orphan Plc (LON: ORPH) is a fast-growing niche CRO (Clinical Research Organisation) pharmaceutical services company. It is one of the leading global firms in the testing of vaccines and antivirals through the use of human challenge clinical trials. In 2019, it bought Venn Life Sciences Holdings Plc, an integrated drug development consultancy, in a reverse takeover. In January 2020, Open Orphan completed the merger with hVIVO Plc, a global player known for testing the effectiveness of antivirals, vaccines, and respiratory disease agents. Established in 2017 and led by a team of experienced professionals, the company has offices in London, Dublin, Paris and the Netherlands. It is a part of the FTSE AIM All-Share.Peers
OPTI
OptiBiotix Health PLC
EAH
ECO ANIMAL HEALTH GROUP PLC
PRTC
PureTech Heath Plc
NFX
Nuformix Plc
TILS
Tiziana Life Sciences PLC
HIK
Hikma Pharmaceuticals Plc
HCM
Hutchmed (China) Limited
ODX
Omega Diagnostics Group plc
ABC
ABCAM PLC
MXC
MGC Pharmaceuticals
AMS
ADVANCED MEDICAL SOLUTIONS GROUP PLC
CREO
Creo Medical Group PLC
Related Articles
Loading...